Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Explore the inspiring stories of the Fierce 50
Pharma
Pharma
FDA flags 'systemic bias' in Amgen's Lumakras trial
An FDA committee is set to determine if the trial was adequate as the agency weighs a potential full approval for Amgen's KRAS inhibitor.
Zoey Becker
Oct 3, 2023 2:23pm
Novo, Lilly, AZ to lead Big Pharma growth through 2030: TD Cowen
Oct 3, 2023 1:50pm
Sponsored
4 Reasons to Take a Fresh Look at Contract Sales Organizations
Oct 2, 2023 8:00am
Galderma's liquid botulinum toxin bid nixed by FDA
Oct 3, 2023 11:14am
AZ agrees to $425M settlement in US over heartburn drugs
Oct 3, 2023 10:57am
After trial flop, Takeda to pull Exkivity worldwide
Oct 3, 2023 9:55am
